Robert Parks

11.8k total citations · 2 hit papers
45 papers, 2.1k citations indexed

About

Robert Parks is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Robert Parks has authored 45 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Virology, 20 papers in Immunology and 12 papers in Infectious Diseases. Recurrent topics in Robert Parks's work include HIV Research and Treatment (27 papers), Immune Cell Function and Interaction (17 papers) and T-cell and B-cell Immunology (9 papers). Robert Parks is often cited by papers focused on HIV Research and Treatment (27 papers), Immune Cell Function and Interaction (17 papers) and T-cell and B-cell Immunology (9 papers). Robert Parks collaborates with scholars based in United States, United Kingdom and France. Robert Parks's co-authors include Barton F. Haynes, Hua‐Xin Liao, David C. Montefiori, Georgia D. Tomaras, Charles B. Hicks, Rory Henderson, Priyamvada Acharya, Robert J. Edwards, Katayoun Mansouri and Katarzyna Janowska and has published in prestigious journals such as Science, Nature Medicine and Nature Communications.

In The Last Decade

Robert Parks

42 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity

2021 247 citations S. Gobeil, Katarzyna Janowska et al. Science profile →
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice

2021 93 citations David R. Martinez, Alexandra Schäfer et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Parks United States	23	1.0k	885	839	675	352	45	2.1k
Carol D. Weiss United States	27	1.6k 1.6×	756 0.9×	1.2k 1.5×	669 1.0×	398 1.1×	65	2.6k
Baoshan Zhang United States	26	1.1k 1.1×	752 0.8×	632 0.8×	648 1.0×	531 1.5×	74	2.2k
D P Bolognesi United States	20	1.4k 1.4×	925 1.0×	662 0.8×	629 0.9×	324 0.9×	39	2.1k
William Honnen United States	25	1.5k 1.5×	857 1.0×	907 1.1×	535 0.8×	583 1.7×	41	2.1k
Brian Gaschen United States	11	1.5k 1.5×	647 0.7×	808 1.0×	768 1.1×	183 0.5×	13	2.3k
D. Noah Sather United States	27	1.3k 1.3×	1.1k 1.3×	557 0.7×	768 1.1×	428 1.2×	70	2.4k
Sanjay Phogat United States	24	1.6k 1.6×	1.2k 1.3×	668 0.8×	751 1.1×	688 2.0×	41	2.3k
Antony S. Dimitrov United States	20	823 0.8×	367 0.4×	853 1.0×	603 0.9×	325 0.9×	36	2.0k
Udy Olshevsky Israel	22	1.4k 1.4×	770 0.9×	1.1k 1.3×	744 1.1×	441 1.3×	38	2.5k

Countries citing papers authored by Robert Parks

Since Specialization

Citations

This map shows the geographic impact of Robert Parks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Parks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Parks more than expected).

Fields of papers citing papers by Robert Parks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Parks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Parks. The network helps show where Robert Parks may publish in the future.

Co-authorship network of co-authors of Robert Parks

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Parks. A scholar is included among the top collaborators of Robert Parks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Parks. Robert Parks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heggestad, Jacob T., David Kinnamon, Daniel Y. Joh, et al.. (2023). COVID-19 Diagnosis and SARS-CoV-2 Strain Identification by a Rapid, Multiplexed, Point-of-Care Antibody Microarray. Analytical Chemistry. 95(13). 5610–5617. 4 indexed citations

Henderson, Rory, Ye Zhou, Victoria Stalls, et al.. (2023). Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage. Nature Communications. 14(1). 2782–2782. 7 indexed citations

Martinez, David R., Alexandra Schäfer, Sarah R. Leist, et al.. (2021). Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice. Science. 373(6558). 991–998. 93 indexed citations breakdown →

Gobeil, S., Katarzyna Janowska, Shana McDowell, et al.. (2021). Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Science. 373(6555). 247 indexed citations breakdown →

Xia, Shi-Mao, Robert Parks, Haiyan Chen, et al.. (2021). Rapid selection of HIV envelopes that bind to neutralizing antibody B cell lineage members with functional improbable mutations. Cell Reports. 36(7). 109561–109561. 4 indexed citations

Gobeil, S., Katarzyna Janowska, Shana McDowell, et al.. (2020). D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction. Cell Reports. 34(2). 108630–108630. 213 indexed citations

Henderson, Rory, Maolin Lu, Ye Zhou, et al.. (2020). Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements. Nature Communications. 11(1). 520–520. 28 indexed citations

Pardi, Norbert, Celia C. LaBranche, Guido Ferrari, et al.. (2019). Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques. Molecular Therapy — Nucleic Acids. 15. 36–47. 75 indexed citations

Negri, Donatella, Maria Blasi, Celia C. LaBranche, et al.. (2016). Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques. Molecular Therapy. 24(11). 2021–2032. 28 indexed citations

10.

Zhang, Ruijun, S. Munir Alam, Jae‐Sung Yu, et al.. (2016). Novel Monoclonal Antibodies for Studies of Human and Rhesus Macaque Secretory Component and Human J-Chain. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 35(4). 217–226. 6 indexed citations

11.

Wang, Yuge, Robert Parks, Aarón Silva-Sánchez, et al.. (2015). HIV-1 gp140 epitope recognition is influenced by immunoglobulin DH gene segment sequence. Immunogenetics. 68(2). 145–155. 11 indexed citations

12.

Alexander, Jeff, Jason Mendy, Lo Vang, et al.. (2013). Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C. PLoS ONE. 8(12). e82380–e82380. 18 indexed citations

13.

Morris, Lynn, Xi Chen, Munir Alam, et al.. (2011). Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting. PLoS ONE. 6(9). e23532–e23532. 106 indexed citations

14.

Dennison, S. Moses, Kara Anasti, Richard M. Scearce, et al.. (2010). Nonneutralizing HIV-1 gp41 Envelope Cluster II Human Monoclonal Antibodies Show Polyreactivity for Binding to Phospholipids and Protein Autoantigens. Journal of Virology. 85(3). 1340–1347. 27 indexed citations

15.

Santra, Sampa, Hua‐Xin Liao, Ruijin Zhang, et al.. (2010). Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nature Medicine. 16(3). 324–328. 185 indexed citations

16.

Gao, Feng, Richard M. Scearce, S. Munir Alam, et al.. (2009). Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins. Virology. 394(1). 91–98. 20 indexed citations

17.

Lambotte, Olivier, Guido Ferrari, Christiane Moog, et al.. (2009). Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS. 23(8). 897–906. 260 indexed citations

18.

Liao, Hua‐Xin, Marc C. Levesque, Ruijun Zhang, et al.. (2009). High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. Journal of Virological Methods. 158(1-2). 171–179. 118 indexed citations

19.

Alam, S. Munir, Richard M. Scearce, Robert Parks, et al.. (2007). Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection. Journal of Virology. 82(1). 115–125. 85 indexed citations

20.

Hurley, David J., Robert Parks, A. Reber, et al.. (2005). Dynamic changes in circulating leukocytes during the induction of equine laminitis with black walnut extract. Veterinary Immunology and Immunopathology. 110(3-4). 195–206. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact